Kindred Biosciences (KIN) 3.94 $KIN Kindred Biosciences

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 4:08 AM

Kindred Biosciences (KIN) 3.94 $KIN

Kindred Biosciences to Announce Second Quarter 2016 Financial Results
PR Newswire - Tue Jul 26, 3:02PM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its second quarter 2016 financial results on August 8, 2016 after the market close. The Company will host a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time that day.
KIN: 3.94 (+0.02)

Kindred Biosciences Announces HITS Sponsorship
PR Newswire - Wed May 25, 3:05PM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, is pleased to announce their Platinum Sponsorship of the HITS Horse Show series. The sponsorship will start this week at the Saugerties, New York facility for the HITS-on-the-Hudson series and will extend through both the HITS Ocala Winter Circuit in Ocala, Florida, and the HITS Desert Circuit in Thermal, California.
KIN: 3.94 (+0.02)

Kindred Biosciences Announces Positive Results from Pivotal Study of KIND-010 for the Management of Weight Loss in Cats
PR Newswire - Mon May 16, 7:30AM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive topline results from its pivotal field study of KIND-010, mirtazapine transdermal gel, for the management of weight loss in cats.
KIN: 3.94 (+0.02)

Kindred Bio reports 1Q loss
Automated Insights - Thu May 05, 7:56AM CDT
BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Thursday reported a loss of $6.1 million in its first quarter.
KIN: 3.94 (+0.02)

Kindred Biosciences Announces First Quarter 2016 Financial Results
PR Newswire - Thu May 05, 7:30AM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the first quarter ended March 31, 2016 and provided updates on its programs.
KIN: 3.94 (+0.02)

Kindred Biosciences Submits KIND-010 New Animal Drug Application Technical Section for Chemistry, Manufacturing, and Controls to FDA
PR Newswire - Wed May 04, 3:02PM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the submission to FDA of the Chemistry, Manufacturing, and Controls (CMC) technical section of the New Animal Drug Application for KIND-010.
KIN: 3.94 (+0.02)

Kindred Biosciences to Announce First Quarter 2016 Financial Results
PR Newswire - Mon Apr 25, 8:02AM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its first quarter 2016 financial results on May 5, 2016 after the market close. The Company will host a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time that day.
KIN: 3.94 (+0.02)

Kindred Biosciences Elects Herbert D. Montgomery to Join Its Board of Directors
PR Newswire - Fri Apr 15, 8:02AM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Mr. Herbert Montgomery will be joining the Company's Board of Directors. Mr. Montgomery will serve as the Chairman of the Company's Audit Committee.
KIN: 3.94 (+0.02)

The Zacks Analyst Blog Highlights: Actelion, Mesoblast, Kindred Biosciences and CorMedix
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 8:30AM CDT
The Zacks Analyst Blog Highlights: Actelion, Mesoblast, Kindred Biosciences and CorMedix
CRMD: 1.49 (unch), MESO: 4.19 (+0.09), KIN: 3.94 (+0.02)

4 Best Biotech Stocks of the First Quarter of 2016
Zacks Equity Research - Zacks Investment Research - Fri Apr 01, 9:03AM CDT
Don't miss these best biotech stocks of the first quarter of 2016.
CRMD: 1.49 (unch), MESO: 4.19 (+0.09), GILD: 80.46 (+0.99), SHPG: 194.00 (-0.12), AMGN: 174.16 (+2.13), BXLT: 46.02 (-0.18), KIN: 3.94 (+0.02)

Kindred Biosciences Submits Final Major New Animal Drug Application Technical Section for Safety for Zimeta to FDA
PR Newswire - Tue Mar 15, 3:01PM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the submission to FDA of the Safety technical section of the New Animal Drug Application (NADA) for Zimeta(TM) (dipyrone injection, KIND-012). This is the final major technical section to be submitted for Zimeta. The Chemistry, Manufacturing, and Controls technical section was submitted in December 2015 and the Effectiveness technical section was submitted in February 2016.
KIN: 3.94 (+0.02)

Kindred Biosciences Releases Positive Results of Pilot Field Study of KIND-010 for the Management of Weight in Cats
PR Newswire - Tue Jan 26, 8:02AM CST
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today released positive results from its pilot field study (KB104P) of KIND-010 for the management of weight in cats. It also announced successful completion of the sample size reassessment of the ongoing pivotal study.
KIN: 3.94 (+0.02)

Kindred Biosciences to Provide Corporate Update
PR Newswire - Thu Jan 07, 8:02AM CST
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will provide a corporate update via webcast on Monday, January 11, 2016 in advance of one-on-one investor meetings in San Francisco January 12-14, 2016.
KIN: 3.94 (+0.02)

Kindred Biosciences submits NADA's CMC to US FDA for KIND-012
M2 - Fri Dec 18, 5:12AM CST
Biopharmaceutical company Kindred Biosciences (NasdaqCM:KIN) said on Thursday that it has submitted the Chemistry, Manufacturing and Controls (CMC) technical section of the New Animal Drug Application (NADA) for KIND-012 to the US FDA.
KIN: 3.94 (+0.02)

A Look Inside the Chart, Technical Insights - Research on Westbury Bancorp, FalconStor Software, Kindred Biosciences and Connecture
ACCESSWIRE - Thu Dec 03, 8:02AM CST
NEW YORK, NY / ACCESSWIRE / December 3, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Westbury Bancorp Inc. (NASDAQ: WBB), FalconStor Software Inc. (NASDAQ: FALC), Kindred Biosciences Inc. (NASDAQ: KIN) and Connecture Inc. (NASDAQ: CNXR). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
CNXR: 2.43 (-0.09), FALC: 1.15 (-0.02), WBB: 19.56 (+0.08), KIN: 3.94 (+0.02)

Kindred Biosciences (KIN) Is in Oversold Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Thu Oct 01, 7:27AM CDT
Kindred Biosciences (KIN) Is in Oversold Territory: What's Next?
KIN: 3.94 (+0.02)

Kindred Biosciences Announces Second Quarter 2015 Financial Results
PR Newswire - Mon Aug 10, 8:02AM CDT
Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the second quarter ended June 30, 2015 and provided updates on its programs.
KIN: 3.94 (+0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kroger, Imprint Team Up for AI-Driven Mastercard

Kroger Teams Up with Imprint for New Credit Card Kroger’s at it again, folks. They're rolling out a shiny new Mastercard, and it's not just any plastic—it’s powered by the AI-driven platform Imprint. Now, what does this mean for you and me? Well, if you're a frequent flyer at Kroger aisles, you might want to pay attention because this card’s offering point...

Varda Space's Dual Launch Signals Orbital Ambitions

It's not every day you see two commercial rockets heading to orbit on the same ride, but that's precisely what Varda Space Industries just pulled off. With the W-8 and W-9 vehicles blasting off together, Varda is positioning itself for a leap in orbital operations. They've hitched a ride aboard SpaceX's Transporter-18 mission, and this is more than just a double...

Athlete Threats: Public Info Fuels Security Risks

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Concrete Pipe: Foundation of Modern Infrastructure

Reinforced Concrete Pipes Hold Their Ground You know, it might not be the flashiest part of our infrastructure toolkit, but concrete pipe plays a mighty big role behind the scenes. Even in this age of shiny new tech and constantly evolving materials, the classic concrete pipe still packs a punch—especially when you demand something that'll last. Enter Stephanie Ward, a...

Nelson-Jameson Boosts Cold Storage in California Move

An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...

SaponiQ Reinvents Body Care with Botanical Soap Bars

Breaking Through with Simple Innovation I'll be the first to say it's not every day you hear about a soap company trying to shake things up in body care like it’s a tech startup, but here’s SaponiQ taking a wild swing at it with their lineup of botanical cleansing bars. These things are whipped up in their own U.S.-based facility using some fancy cold-process...

Maternal Health Index: A New Tool With Big Ambitions

A Fresh Take on Maternal Health Today's all about the Heartland Forward's fresh tool, the Maternal Resiliency Index. It's making a splash at the 2026 Heartland Summit with a lot of promise on its shoulders. Backed by economists and health gurus like Emily Oster and Dr. Neel Shah, this index ain't your run-of-the-mill tool. It's here to shake the couch coins out of...

Ace Hardware Ups the Stakes with Rewards Days Event

Ace Hardware: Doubling Down with Rewards Ace Hardware's rolling out the red carpet for its loyal customers. Imagine this: exclusive deals on trusted brands and double points on purchases—an incentive any savvy shopper would jump at. From October 6 to 7, those in the Ace Rewards circle have the chance to nab some hefty savings and perks, a move that's more than just a...

Nukleus Launches Unified Platform for Athletes' Business

Leveling the Business Field for Athletes Athletes spend their lives fighting for every inch on the field, and now Nukleus is giving them the tools to hold ground off it. Why should they be the last ones to know their own business? Ashton Jeanty and Nukleus got tired of that narrative and kicked off a platform today with a real promise: putting an athlete's entire business...